Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patents · clear
Ajinomoto Co., Inc. vs. CH Cheiljedang Corp. (2018-1590, 2018-1629) In a pair of cross-appeals from the International Trade Commission, the Federal Circuit affirmed the Commission’s ruling that one of CJ CheilJedang Corp.’s engineered bacterial…
On April 1, 2019, the Federal Circuit issued a non-precedential decision in Cleveland Clinic Foundation, Cleveland HeartLab, Inc. v. True Health Diagnostics LLC (“ Cleveland Clinic II ”), affirming the district court’s holding that claim…
A New Jersey jury awarded Mondis $45 million in patent damages, based on LG’s sales of infringing televisions that support the “Plug & Play” standard. The “Plug & Play” standard was promulgated by the Video Electronics…
In Natural Alternatives International, Inc. v. Creative Compounds, LLC . , Appeal No. 2018-1295, a divided panel of the Federal Circuit reversed and remanded a decision by the District Court for the Southern District of California that granted a judgment…
2018 is over and it is time to review innovation activity for the year. In 2018, there were a total of 341,098 patents issued, which is about 3.3 percent lower than the prior year. However, this number shows an increase of about 4 percent in a 5-year…
Federal Circuit Summary On September 10, 2018, the Federal Circuit decided Regents of the University of California v. Broad Institute, Inc. , affirming the Patent Trial and Appeal Board (PTAB)’s determination of no interference-in-fact between the…
A new infertility technique, mitochondrial replacement therapy (MRT), has been used to create so called “three-parent” babies. MRT is used in cases when mothers carry genes for mitochondrial diseases. Similar to in vitro fertilization (IVF),…
In two recent cases, the Federal Circuit addressed the role of factual questions in resolving patent eligibility under 35 U.S.C. § 101. The first case was Berkh eimer v. HP Inc. and the second was Aatrix Software v. Gree n Shades Software.[1] These…
BioArctic AB, a public Swedish biopharma company, recently announced that they received allowance of a patent application directed to a method of promoting axonal regeneration using a biodegradable spinal cord device. The medical device is said to be a…
In Regeneron Pharmaceuticals v. Merus N.V. , [16-1346] the Federal Circuit denied rehearing and rehearing en banc the July panel decision, previously discussed here , that litigation misconduct warranted a finding of inequitable conduct in patent…
The Federal Circuit recently faced a patent marking issue in Arctic Cat Inc. v. Bombardier Recreational Products Inc., [2017-1475] (December 8, 2017). In that case, the patent owner Arctic Cat had previously licensed the patents in suit to Honda. The…
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar,(1) Celltrion’s partner Pfizer has filed a suit against Janssen’s…
